Overview

Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Primary Objectives: 1. To determine the feasibility and toxicity of employing purine-analog based conditioning for allogeneic donor stem cell transplantation in patients with severe aplastic anemia (AA). 2. To determine the engraftment kinetics and degree of chimerism that can be achieved with this strategy.
Phase:
N/A
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Antilymphocyte Serum
Cyclophosphamide
Fludarabine
Fludarabine phosphate
Thymoglobulin
Vidarabine